Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19

NCT04747249 | Completed

• 1 other identifier: 2020-A03234-35
• Study Type: interventional
• Target: 29
• Locations: 1 country
• Sites: 1

Brief Summary

In the context of the COVID-19 pandemic, concerns of the risk of infection may lead to fear, anxiety or psychological disorders that may become generalised and long-lasting, corresponding to post-traumatic stress disorder (PTSD). PTSD generally occurs in circumstances such as terrorist attacks, hostage-taking, bombings, aggression, accidents... The current health crisis also represents an increased risk of PTSD. After the first moments of stress, the illness becomes more diffuse: personality change (introverted/extraverted), sleep disorders, heart problems, hypervigilance reaction, agoraphobia, symptoms of reminiscence, irritability, decreased concentration, memory loss... In some people, PTSD can lead to more disabling problems such as (crowd) avoidance. In order to help patients with PTSD, clinical psychology offers therapeutic approaches which, starting from a debriefing with the patient, provide supportive therapy which (i) reassures by providing information on the symptomatology, in order to play down the present state of mind, (ii) allows for the expression of what was experienced during the event, (iii) initiates a process of elaboration of the trauma through transference. A study initiated at the François Baclesse Centre during the first confinement, which included 735 patients from April to June 2020, made it possible to assess the impact of the pandemic linked to COVID-19 on the care of cancer patients treated in day hospitals, but also to evaluate the PTSD experienced by patients, sleep difficulties, quality of life, cognitive complaints and confinement conditions using validated questionnaires. This study showed that 21% of patients had proven PTSD and 23% had insomnia problem. This study proposes to evaluate the value of adapted psychological care for patients with PTSD in relation to the pandemic on the improvement of PTSD, as well as on resilience, quality of life and sleep.

Conditions

Solid Carcinoma; Post Traumatic Stress Disorder; Covid19

Outcome Measures

Primary Outcomes (1)

• Proportion of patients with improvement in post-traumatic stress symptoms

  6 months

Secondary Outcomes (1)

• Resilience Scores

  6 months

Study Arms (1)

Psychological support

EXPERIMENTAL

Monthly psychological support

Other: Psychological support

Interventions

Psychological support OTHER

Psychological care will be based on a monthly interview lasting approximately 45 minutes for 6 months.

Psychological support

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient ≥ 18 years old
• Patient treated or followed up for a solid tumour at the François Baclesse Centre
• Patient with a score suggesting moderate or high posttraumatic stress symptoms (IES-R score ≥ 24) related to the COVID-19 epidemic
• The patient's state of health is compatible with the programme: psychological care for 6 months.
• Information note signed by the patient
• Any associated geographical, social or psychopathological conditions that might compromise the patient's ability to participate in the study

You may not qualify if:

• Patient with no symptoms suggestive of moderate or high post-traumatic stress (IES-R score \<24)
• Patient deprived of liberty or under guardianship
• Patient already receiving psychological care
• Patient whose diagnosis of the disease was made within one month prior to the proposal for participation

Sponsors & Collaborators

• Centre Francois Baclesse: lead

Study Sites (1)

Centre Francois Baclesse

Caen, France

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic; COVID-19

Condition Hierarchy (Ancestors)

Stress Disorders, Traumatic; Trauma and Stressor Related Disorders; Mental Disorders; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Antony NARAYANASSAMY, M

  Centre François Baclesse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Psychological support

Study Record Dates

• First Submitted: February 8, 2021
• First Posted: February 10, 2021
• Study Start: June 18, 2021
• Primary Completion: March 31, 2022
• Study Completion: September 5, 2022
• Last Updated: August 1, 2023

Record last verified: 2023-07

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)